Buy these 2 high-quality ASX 200 shares: brokers

These businesses have a compelling future, analysts have buy ratings on them.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • S&P/ASX 200 shares, like REA Group and TechnologyOne, have competitive advantages and long-term growth potential, earning "buy" ratings from UBS.
  • UBS praises REA Group's strong FY25 performance with substantial revenue and profit growth, emphasizing its market leadership and ability to leverage cost and yield growth for future expansion.
  • UBS is optimistic about TechnologyOne's revenue retention and profit margins, driven by successful product transitions and strong customer engagement, forecasting continued impressive growth through 2028.

High-quality S&P/ASX 200 Index (ASX: XJO) shares can make the best investments thanks to their competitive advantages, which allow them to make big profits and continue reinvesting for further long-term growth.

Quality can be measured in a number of different ways, with an economic moat(s) playing an important part in the equation. Some businesses have excellent brand power, intellectual property, great margins and so on.

The two ASX 200 shares I'm going to talk about are both rated as buys by the broker UBS.

Buy now written on a red key with a shopping trolley on an Apple keyboard.

Image source: Getty Images

REA Group Ltd (ASX: REA)

UBS describes REA Group as an online advertising business in the real estate space. Its key flagship site is realestate.com.au. It has a number of other Australian real estate businesses, including a mortgage broking business. It also has a majority stake in REA India.

The broker currently has a buy rating with a price target of $290 on the high-quality ASX 200 share because of the strength of the business, combined with its positive outlook. UBS notes the FY25 result was strong, with 15% revenue growth flowing through to 23% net profit after tax (NPAT) growth.

UBS is impressed by how REA Group continues to entrench its market leadership, with a 55% increase in seller leads and four times more audience visits compared to its nearest competitor (of which 50% is reportedly exclusive to REA Group).

The broker points out the business provided FY26 guidance of double-digit yield growth and high single-digit cost growth. The yield growth is set to be supported by a 7% price rise.

The cost growth factors in a large increase in marketing spending ahead of CoStar's entry into the market (via the acquisition of Domain), though AI-driven and other cost efficiencies provide offsets.

The broker thinks there's a promising outlook for the business with higher auction clearance rates, while the business could claim a higher percentage of the overall marketing spend. UBS believes there's a significant runway for further growth.

At the current REA Group share price, UBS' estimates the business is trading at 45x FY26's estimated earnings.

TechnologyOne Ltd (ASX: TNE)

The other high-quality ASX 200 share I'll highlight that UBS rates as a buy is TechnologyOne, an enterprise software provider. It offers software solutions across various industries including local, state and federal governments, financial services, education, utilities, health and community services.

UBS has a buy rating on the business, with a price target of $42.20.

A key diver for the business is its net revenue retention (NRR), which reveals how much revenue it retained from its existing client base compared to last year. The company has a goal of 115% NRR, implying a 15% annual increase in revenue from subscribers. UBS says the business is successfully upselling and rolling out 'SaaS+' which is a version of software as a service (SaaS) offering. The NRR is supported by very low customer churn.

UBS asked itself the question of whether the 115% NRR rate can continue. The broker wrote:

Yes, based on strong traction with new product initiatives like the DXP and SaaS+, with runway ahead as the legacy 'Ci' product is transitioned to the 4th gen 'CiA' product. We forecast 116% pa NRR over FY25-26 and 115% FY27, at the lower end of its 115-120% pa target range (but still impressive).

The broker also asked whether the high-quality ASX share would be able to achieve a 35% profit before tax (PBT) margin by FY28. UBS said:

Yes, supported by strong top-line growth driving some operating leverage over time, offsetting the initial margin impact from the transition to SaaS+. We expect TNE to achieve its targeted 35% PBT margins by FY28, which incorporates R&D investment in the 20-25% of sales indicative range over this period.

The TechnologyOne share price is trading at 77x FY26's UBS' estimated earnings.  

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A graphic image of the world globe surrounded by tech images is superimposed on the setting of an office where three businesspeople are speaking together while standing.
Growth Shares

Is the TechnologyOne share price an opportunity too good to pass up?

Should investors look at this tech stock as a great opportunity?

Read more »

A man leaps as high as he can over his friends into a pool.
Share Market News

Down 42% this year, is it time to jump into Life360 shares?

Crashing shares: golden opportunity or value trap?

Read more »

Soldier in military uniform using laptop for drone controlling.
Growth Shares

After a rollercoaster start to the year, are Droneshield shares headed up?

Droneshield shares look cheap after a rollercoaster past twelve months.

Read more »

Two lab workers fist pump each other.
Growth Shares

Why Pro Medicus shares could still have their best years ahead

Pro Medicus has been through a rough patch. With future growth catalysts and durable competitive advantages, brokers are tipping this…

Read more »

Green arrow going up on stock market chart, symbolising a rising share price.
Growth Shares

2 exciting ASX shares to buy with big growth potential!

Fund managers are excited about the prospective returns of these stocks.

Read more »

A couple are happy sitting on their yacht.
Growth Shares

Retire rich with these ASX growth shares

These companies will have ups and downs, but their long-term opportunities could make them worth holding for years.

Read more »

A young girl child empties coins out of her piggy bank with mum smiling over her shoulder.
Growth Shares

Down 50%, these 2 ASX growth shares look too cheap to ignore

Here's 2 beaten-down ASX growth shares to buy in May.

Read more »

Excited couple celebrating success while looking at smartphone.
Growth Shares

Where to invest $20,000 in ASX 200 shares this week

These shares have qualities that make them attractive long-term picks.

Read more »